New assignment to establish innovation hubs for the production of vaccines and advanced drugs

"Competitiveness is created by contributing to solutions to important challenges - and the pandemic has reminded us of the importance of research, innovation and international collaboration in the field of health," says Darja Isaksson, DG Vinnova.

The task of establishing the innovation hub to promote competence and capacity development is a clear step in the direction we pointed out in the report on Sweden's capacity to produce vaccines. The report was submitted to the Government this spring

- We look forward to contributing to an open innovation environment for advanced drug production in Matfors for the benefit of Swedish competitiveness, our preparedness for future challenges and international collaborations. This is an important piece of the puzzle that complements Sweden's already strong life science sector.

Report from Vinnova: Sweden's innovation and production capacity for vaccines and other biological drugs

Press release from the Government: Swedish effort on innovation hub to enable production of advanced drugs and vaccines

See Minister of Trade and Industry Ibrahim Baylans press conference on innovation hubs for advanced drugs and vaccines in Sweden

Minister of Trade and Industry Ibrahim Baylans press conference on the assignment to Vinnova to establish an innovation hub for the production of vaccines and advanced drugs. The press conference was held together with Darja Isaksson, director general of Vinnova, and Thomas Eldered, CEO of Flerie Invest.